Visualitzant - Articles científics per títol

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Wainberg, Zev; Melisi, Davide; Pazo-Cid, Roberto A.; Chandana, Sreenivasa R; DE LA FOUCHARDIERE, CHRISTELLE; Macarulla, Teresa (Elsevier, 2023-10-07)

Nanoceria as Safe Contrast Agents for X-ray CT Imaging

García, Ana; Cámara Serrano, Juan Antonio; Mondragon Martinez, Laura; Franco Puntes, Victor; BOULLOSA GOBERNA, ANA MARIA; Freixanet Gusta, Muriel; Schwartz, Simo; Abasolo, Ibane (MDPI, 2023-07-29)

Nanoceria dissolution at acidic pH by breaking off the catalytic loop

Galyamin, Dmitry; Montaña Ernst, Lena Nerea; Fito Parera, Aina; Mira-Vidal, Guillem; Bastús, Neus G; Sabaté, Neus; Franco Puntes, Victor (Royal Society of Chemistry, 2022-10-06)

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

Bekaii-Saab, Tanios S; Okusaka, Takuji; Goldstein, David; Ueno, Makoto; Ioka, Tatsuya; Tabernero Caturla, Josep; Oh, Do-Youn (Elsevier, 2023-04)

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea

Jurado Luque, Ma Jose; Quintana Luque, Manuel; Romero Santo-Tomas, Odile; Cambrodí i Masip, Roser; Ferré Masó, Alejandro; Sampol Sirvent, Julia; Sampol Rubio, Gabriel (Elsevier, 2022-11)

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

Cortellini, Alessio; Aguilar Company, Juan; Salazar, Ramón; Bower, Mark; Sita-Lumsden, Ailsa; Plaja, Andrea (Springer Nature, 2022-11-09)

Near-normal aerobic capacity in long-term survivors after lung transplantation

Saez Gimenez, Berta; Barrecheguren Fernández, Miriam; Ramon Belmonte, Maria Antonia; Gómez Garrido, Alba; Monforte Torres, Victor; Berastegui Garcia, Cristina; Revilla Lopez, Eva Maria; Román Broto, Antonio; Gómez Olles, Susana; Ojanguren Arranz, Iñigo; Romero Mesones, Christian Eduardo; López Meseguer, Manuel; Bravo Masgoret, Carles (European Respiratory Society, 2021-02-01)

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis

Fletcher Sanfeliu, Delfina; Millán Scheiding, Mónica; Primo-Romaguera, Vicent; Garcia Gausi, Maria; Pellino, Gianluca; Garcia-Granero, Alvaro (Springer, 2022-03)

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

Pascual, Tomás; Antunes de Melo Oliveira, Ana Mafalda; Villagrasa, Patricia; Ortega Cebrian, Vanesa; Bermejo, Begoña; Nuciforo, Paolo Giovanni; Rubio Rodríguez, Isabel Teresa; Cortés Castan, Javier; Paré, Laia (Nature Research, 2021-11-25)

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach

Figueras Coll, Marc; Fidalgo García, Andrea; Martí Aguascas, Gerard; Betrián Blasco, Pedro (Permanyer Publications, 2023)

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center

Marín Córdoba, Carlota; Camba, Fatima; Montaner Ramón, Alicia; Morey-Olivé, Miriam; RODO, CARLOTA; Arévalo Martínez, Silvia; Maiz, Nerea (Elsevier, 2024-02)

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model

Salas Torras, Anna; Badia Pérez, Anna; Fontrodona Montals, Laura; Zapata, Miguel Angel ; Garcia-Arumi, Jose; Duarri, Anna (MDPI, 2023-09-02)

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer

Lizakowski, Slawomir; Dębska-Ślizień, Maria Alicja; Kurnatowska, Ilona; Zaucha, Jan Maciej; Matuszewski, Marcin; Naumnik, Beata; Ferrandiz-Pulido, Carla (Polish Biochemical Society, 2023-05-09)

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Oaknin Benzaquen, Ana Mazaltob; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Braña Garcia, Irene; Bidard, François-Clement (Elsevier, 2020-10)

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Antunes de Melo Oliveira, Ana Mafalda; Feng, Yin-Hsun; Dai, Ming-Shen; Chen, Shang-Wen; Hurvitz, Sara; Saura Manich, Cristina (American Society of Clinical Oncology, 2020-09-20)

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Moy, Beverly; Antunes de Melo Oliveira, Ana Mafalda; Gradishar, William; Kim, Sung‑Bae; Brufsky, Adam; Saura Manich, Cristina (Oxford University Press, 2021-07)

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes

Gil Moreno, Antonio; Carbonell Socias, Melchor; Salicrú Riera, Sabina; Bradbury Lobato, Melissa; García Jiménez, Angel; Vergés Capdevila, Ramona; Puig Puig, Oriol; Sánchez Iglesias, José Luis; Cabrera Diaz, Silvia; De la Torre Fdez de Vega, Fco Javier; Perez Benavente, Maria Asuncion; Rodriguez Gómez-Hidalgo, Natalia; Díaz-Feijoo, Berta (Impact Journals, 2019-07-16)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant HVH - Articles científics per títol

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Nanoceria as Safe Contrast Agents for X-ray CT Imaging

Nanoceria dissolution at acidic pH by breaking off the catalytic loop

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

Near-normal aerobic capacity in long-term survivors after lung transplantation

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes

Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

Neurodevelopmental outcomes in congenital heart disease: Usefulness of biomarkers of brain injury

Neurodevelopmental phenotypes in individuals with pathogenic variants in CHAMP1

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant HVH - Articles científics per títol

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial ﻿

Nanoceria as Safe Contrast Agents for X-ray CT Imaging ﻿

Nanoceria dissolution at acidic pH by breaking off the catalytic loop ﻿

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial ﻿

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea ﻿

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer ﻿

Near-normal aerobic capacity in long-term survivors after lung transplantation ﻿

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis ﻿

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial ﻿

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach ﻿

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center ﻿

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model ﻿

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer ﻿

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial ﻿

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial ﻿

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens ﻿

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes ﻿

Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis ﻿

Neurodevelopmental outcomes in congenital heart disease: Usefulness of biomarkers of brain injury ﻿

Neurodevelopmental phenotypes in individuals with pathogenic variants in CHAMP1 ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Nanoceria as Safe Contrast Agents for X-ray CT Imaging

Nanoceria dissolution at acidic pH by breaking off the catalytic loop

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

Near-normal aerobic capacity in long-term survivors after lung transplantation

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes

Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

Neurodevelopmental outcomes in congenital heart disease: Usefulness of biomarkers of brain injury

Neurodevelopmental phenotypes in individuals with pathogenic variants in CHAMP1